Ibhanti kunye nendlela: Intsebenziswano, uVumelwano kunye nokuphumelela phakathi koBuntu
iimveliso

Iimveliso

I-Liraglutide CAS:204656-20-2 Umthengisi woMvelisi

I-Liraglutide, i-lipopeptide kunye ne-polypeptide, yi-analogue ye-human GLP-1 apho i-lysine residue kwindawo yama-27 ithathelwa indawo yi-arginine kunye neqela le-hexadecanoyl elinamathele kwi-lysine eseleyo nge-glutamic acid spacer. Isetyenziswa kunye nokutya kunye nokuzilolonga ukuphucula ulawulo lwe-glycemic kubantu abadala abanesifo seswekile sohlobo lwesibini. I-Liraglutide isebenza njenge-glucagon-like peptide-1 receptor agonist kwaye isebenza njenge-neuroprotective agent.


Iinkcukacha zeMveliso

Iithegi zeMveliso

Ukusetyenziswa kunye nesiphumo

I-Liraglutide luhlobo olutsha lweyeza elinciphisa i-hypoglycemia elivuselela i-AMP-activated protein kinase ngaloo ndlela liphucula uvakalelo lwe-insulin. Ayinasiphumo sibalulekileyo se-hypoglycemic kuphela, kodwa ikwanayo nemisebenzi yokunciphisa umzimba, ukunciphisa uxinzelelo lwegazi, kunye nokuphucula iprofayili yamafutha egazini. I-Liraglutide, i-peptide-1 (GLP-1) receptor agonist yomntu, inciphisa ukukhupha isisu, inyusa ukugcwala, kwaye inciphisa ukutya kwesigulane, ngelixa inciphisa umnqweno wobuchopho wokutya kwaye ivumela umzimba ukuba usebenzise amandla amaninzi. Ukunyuka kwenkcitho yamandla kudlala indima ekunciphiseni ubunzima; ithintela isibindi ekuveliseni i-glucose eninzi kwaye ikhuthaza i-pancreas ukuba ivelise i-insulin engaphezulu ukuze inciphise iswekile yegazi; ukongeza, i-liraglutide ikwanazo neengenelo zentliziyo kunye nokukhuselwa kwezintso.

Isampuli yeMveliso

图片282(1)
图片260(1)

Ukupakisha imveliso:

图片283(1)

Iinkcukacha ezongezelelweyo:

Ukwakhiwa C172H265N43O51
Uvavanyo 99%
Inkangeleko Umgubo omhlophe
Inombolo ye-CAS 204656-20-2
Ukupakisha 25KG
Beka ubomi kwishelufa iminyaka eyi-2
Indawo yokugcina izinto Gcina kwindawo epholileyo neyomileyo
Isiqinisekiso I-ISO.

  • Ngaphambili:
  • Okulandelayo:

  • Bhala umyalezo wakho apha uze uwuthumele kuthi